# ARI103094-Follow-Up Study for REDUCE Study Subjects

> **NCT00883909** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 2795 (actual)

## Conditions studied

- Neoplasms, Prostate

## Interventions

- **DRUG:** dutasteride

## Key facts

- **NCT ID:** NCT00883909
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-09
- **Primary completion:** 2010-12-01
- **Final completion:** 2010-12-29
- **Target enrollment:** 2795 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883909, "ARI103094-Follow-Up Study for REDUCE Study Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00883909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*